Navin Fluorine International

Navin Fluorine International

5,969.00
-112.00
(-1.84%)
hide
Key Fundamentals
Add Ratio
Market Cap
31,138.20 Cr
EPS
58.20
PE Ratio
68.89
Dividend Yield
0.11 %
Industry
Chemicals
52 Week High
6,138.00
52 Week Low
3,180.00
PB Ratio
8.50
Debt to Equity
0.57
Analyst Rating and Forecast
- By Refinitiv from23 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+69.57 %
+69.57 %
Hold
Hold+13.04 %
+13.04 %
Sell
Sell+17.39 %
+17.39 %
Forecast For
Actual

Company News

View All News
Caret
positive
Navin Fluorine International Limited reported quarterly revenue of INR 758 crores, marking 46% year-on-year growth. Operating EBITDA reached INR 246 crores with margins at 32.5% versus 20.7% in the previous year. Profit after tax more than doubled to INR 148 crores from INR 59 crores. For the half-year, revenue grew 42% to INR 1,484 crores with EBITDA at INR 453 crores. The Board declared an interim dividend of INR 6.5 per share and approved two strategic capex projects totaling INR 311.5 crores. The first involves INR 236.5 crores for additional HFC capacity equivalent to 15,000 metric tonnes per annum of R32, expected to generate peak annual revenue of INR 600-825 crores. The second is a INR 75 crore debottlenecking of MPP capacity with potential revenue of INR 140-160 crores per annum. Both projects will be funded through internal accruals. All three business divisions - HPP, Specialty, and CDMO - reported good growth, with the company maintaining optimistic outlook for sustained momentum.
positive
Navin Fluorine has revised its EBITDA margin expectations for FY26 to 28-30%, surpassing its initial guidance of 25%. The company has outlined a capital expenditure framework of approximately ₹1,000 crore for the coming years.
positive
Navin Fluorine has projected 42% sales growth for FY26 alongside a 118% increase in EBITDA. The company plans ₹310 crore in capital expenditure for HFC and MPP debottlenecking activities targeting global innovators. The company expects margins above 30% driven by specialty chemicals, CDMO scale-up operations, and maintains order book visibility extending through FY27.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,454.80
#1 1,46,835.80
65.93
13,387.50
6.91
#1 2,096
8.20
40.02
2,896.80
85,942.40
53.11
14,825.80
12.13
1,251
92.75
38.02
3,614.00
40,056.80
63.86
4,853.20
10.61
546
70.37
44.43
5,969.00
#4 31,138.20
#10 68.89
#8 2,393.10
#4 12.83
#10 289
#1 152.38
76.85
1,720.60
23,630.10
38.68
8,365.80
7.84
697
-44.54
35.11
4,448.60
19,025.80
48.63
#1 15,339.40
10.81
479
-37.72
44.97
1,643.50
17,317.30
39.10
2,292.50
18.24
405
10.06
38.81
5,691.00
16,959.90
#1 29.79
5,692.40
#1 18.99
499
30.75
34.76
391.80
14,159.30
48.98
7,285.40
14.16
331
103.85
59.51
4,351.70
13,451.10
32.92
2,366.70
7.83
411
-7.50
30.65
Growth Rate
Revenue Growth
12.83 %
Net Income Growth
6.69 %
Cash Flow Change
-23.88 %
ROE
-3.17 %
ROCE
2.45 %
EBITDA Margin (Avg.)
12.70 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
260
262
245
264
258
282
272
282
251
329
320
375
335
349
386
421
408
430
574
701
499
495
564
615
534
530
617
713
739
777
Expenses
192
203
182
201
190
205
195
208
161
228
230
252
249
255
280
315
298
325
408
495
377
374
425
492
423
411
459
522
519
512
EBITDA
68
59
63
63
68
77
77
75
90
100
90
123
87
95
106
107
110
105
166
206
123
121
140
123
111
119
158
191
221
264
Operating Profit %
25 %
20 %
22 %
20 %
24 %
25 %
25 %
25 %
25 %
28 %
26 %
25 %
24 %
25 %
26 %
23 %
25 %
22 %
28 %
29 %
23 %
21 %
15 %
18 %
19 %
21 %
24 %
26 %
29 %
32 %
Depreciation
7
7
7
7
8
9
9
11
11
11
11
12
12
12
12
12
12
18
25
8
21
24
25
26
27
28
30
35
35
37
Interest
0
0
0
0
1
0
1
1
0
0
0
1
1
0
0
1
0
4
9
14
19
20
18
17
16
14
20
28
30
30
Profit Before Tax
60
52
56
56
59
68
67
63
79
89
79
111
74
82
94
94
97
83
131
184
82
77
97
79
68
77
108
127
155
198
Tax
22
15
17
21
16
21
22
-210
23
21
20
36
18
19
25
19
23
25
25
48
20
17
19
9
17
18
24
32
38
49
Net Profit
38
37
39
35
43
47
45
273
56
68
59
75
56
63
69
75
74
58
107
136
62
61
78
70
51
59
84
95
117
148
EPS in ₹
7.70
7.54
7.81
7.11
8.72
9.57
9.18
55.11
11.32
13.70
11.90
15.11
11.29
12.77
13.89
15.17
15.02
11.67
21.50
27.51
12.41
12.22
15.74
14.20
10.33
11.86
16.86
19.15
23.63
29.06

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
852
955
1,177
1,256
1,307
1,629
1,898
2,386
3,529
4,377
4,830
Fixed Assets
274
375
562
428
430
529
540
556
1,646
1,875
2,736
Current Assets
311
347
467
565
561
778
1,195
1,019
1,386
1,553
1,589
Capital Work in Progress
60
20
17
20
39
39
95
742
279
711
355
Investments
55
53
239
428
427
195
99
118
44
495
480
Other Assets
462
507
360
380
410
866
1,163
969
1,561
1,297
1,259
Total Liabilities
852
955
1,177
1,256
1,307
1,629
1,898
2,386
3,529
4,377
4,830
Current Liabilities
164
196
280
211
177
177
202
384
522
787
915
Non Current Liabilities
87
113
63
61
58
39
62
157
823
1,208
1,290
Total Equity
601
645
835
984
1,072
1,412
1,634
1,844
2,185
2,383
2,626
Reserve & Surplus
578
636
825
974
1,063
1,402
1,624
1,834
2,175
2,373
2,616
Share Capital
10
10
10
10
10
10
10
10
10
10
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-17
6
10
-6
-3
161
-45
-56
-61
-8
13
Investing Activities
3
-53
-16
-136
-24
85
-237
-172
-656
-1,094
-511
Operating Activities
1
76
92
169
90
157
237
75
-64
750
571
Financing Activities
-21
-17
-67
-39
-68
-81
-45
42
658
336
-47

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sept 2025
Promoter
30.22 %
30.22 %
30.20 %
30.19 %
29.70 %
29.70 %
29.40 %
29.40 %
28.81 %
28.81 %
28.81 %
28.81 %
28.81 %
28.80 %
28.44 %
28.44 %
28.44 %
28.01 %
27.14 %
27.12 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
15.92 %
15.57 %
18.02 %
18.23 %
18.55 %
20.16 %
21.55 %
21.98 %
22.15 %
DIIs
13.40 %
12.44 %
12.46 %
13.13 %
15.35 %
17.67 %
19.12 %
23.78 %
24.84 %
25.97 %
19.78 %
28.92 %
28.61 %
27.41 %
28.18 %
28.46 %
30.04 %
28.71 %
29.88 %
29.57 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.58 %
23.08 %
23.17 %
23.45 %
23.19 %
23.26 %
22.04 %
21.67 %
21.08 %
21.06 %
20.24 %
21.19 %
22.00 %
20.98 %
20.17 %
19.33 %
16.96 %
17.17 %
16.59 %
16.73 %
Others
32.80 %
34.26 %
34.17 %
33.23 %
31.76 %
29.36 %
29.45 %
25.15 %
25.27 %
24.17 %
31.17 %
5.16 %
5.01 %
4.79 %
4.98 %
5.22 %
4.40 %
4.57 %
4.41 %
4.43 %
No of Share Holders
1,25,924
1,39,517
1,58,932
1,63,375
1,73,418
1,67,777
1,60,394
1,53,733
1,50,596
1,49,581
1,47,191
1,72,816
1,82,759
1,71,968
1,65,231
1,59,041
1,39,007
1,38,398
1,38,522
1,37,981

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 21 31.5 10 7.8 11 11 11 12 15 7
Dividend Yield (%) 3.45 4.08 1.41 0.64 0.4 0.27 0.26 0.39 0.36 0.12

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
07 Nov 2025 DIVIDEND Dividend
₹ 6.50 /share
07 Nov 2025 4,976.40 6,081.00
13 Jul 2021 DIVIDEND Dividend
₹ 6.00 /share
09 Jul 2021 3,624.00 3,861.35
02 Nov 2021 DIVIDEND Dividend
₹ 5.00 /share
01 Nov 2021 3,867.00 3,361.50
08 Jul 2022 DIVIDEND Dividend
₹ 6.00 /share
07 Jul 2022 3,756.55 3,793.70
04 Nov 2022 DIVIDEND Dividend
₹ 5.00 /share
03 Nov 2022 4,286.80 4,497.75
07 Jul 2023 DIVIDEND Dividend
₹ 7.00 /share
07 Jul 2023 4,748.00 4,616.25
10 Nov 2023 DIVIDEND Dividend
₹ 3.00 /share
10 Nov 2023 3,424.15 3,597.25
10 Nov 2023 DIVIDEND Dividend
₹ 5.00 /share
10 Nov 2023 3,438.10 3,597.25
05 Jul 2024 DIVIDEND Dividend
₹ 7.00 /share
05 Jul 2024 3,436.40 3,656.55
01 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
01 Aug 2024 3,574.60 3,802.40
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 3,366.90 3,221.00
07 Nov 2024 DIVIDEND Dividend
₹ 5.00 /share
07 Nov 2024 3,221.00 3,502.45
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 3,304.70 3,740.20
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 May 2025 4,196.20 4,550.85
04 Jul 2025 DIVIDEND Dividend
₹ 7.00 /share
04 Jul 2025 4,550.85 4,874.30
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2025 4,613.00 5,147.75
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 4,550.85 5,189.60
30 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2025 4,713.30 4,976.40

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript3 days ago
Clarification Regarding Significant Increase In Volume4 days ago
Clarification sought from Navin Fluorine International Ltd4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Newspaper Advertisement Of The Financial Results For The Quarter And Half Year Ended 30Th September 20257 days ago
Communication To Shareholders - Intimation Regarding Tax Deduction On Dividend8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome8 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report8 days ago
Intimation Of Record Date For Ascertaining Members Eligible For The Payment Of Interim Dividend For The Financial Year 2025-20268 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation8 days ago
Capital Expenditure Of INR 236.50 Crores For Setting Up An Additional HFC Capacity Upto 15K MTPA R32 Equivalent Quantity And Capital Expenditure Of INR 75 Crores For Debottlenecking Of Multi Purpose Plant (MPP)8 days ago
Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30 20258 days ago
Board Meeting Outcome for October 30 20258 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 27, 2025
Closure of Trading WindowSep 23, 2025
Update on board meetingSep 23, 2025
Board Meeting Intimation for Inter-Alia To Consider Approve & Take On Record Unaudited Standalone & Consolidated Financial Results For The Quarter & Half Year Ending September 30 2025; & To Consider Declaration Of Interim Dividend For The Financial Year 2Sep 23, 2025
Newspaper AdvertisementSep 19, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 18, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Update On New Cgmp-4 Facility At DewasSep 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionAug 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 25, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 23, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 07, 2025
Announcement under Regulation 30 (LODR)-AcquisitionAug 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 01, 2025
Newspaper Advertisement - Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Aug 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Newspaper Advertisement Of The Financial Results For The Quarter Ended 30Th June 2025Jul 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025Jul 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On July 30 2025Jul 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 26, 2025
Announcement under Regulation 30 (LODR)-AllotmentJul 11, 2025
Qualified Institutions Placement Of Equity Shares Of Face Value ?2 Each (The Equity Shares) By Navin Fluorine International Limited (The Company) Under The Provisions Of Chapter VI Of Securities And Exchange Board Of India (Issue Of Capital And DisclosureJul 11, 2025
Qualified Institutions Placement Of Equity Shares Of Face Value ?2 Each (The Equity Shares) By Navin Fluorine International Limited (The Company) Under The Provisions Of Chapter VI Of The Securities And Exchange Board Of India (Issue Of Capital And DiscJul 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 10, 2025
Letter Containing Web Link Of Annual Report 2024-25Jul 09, 2025
Notice FY 2024-25Jul 09, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
SBI Small Cap Fund Direct-Growth
0.00%
-1500000
-1.95%
-2.00%
Nippon India Small Cap Fund Direct- Growth
0.00%
-567368
-0.40%
-0.41%
Axis Small Cap Fund Direct-Growth
0.00%
-522648
-0.93%
-0.96%
DSP Small Cap Direct Plan-Growth
0.00%
-500000
-1.40%
-1.41%
Axis ELSS Tax Saver Direct Plan-Growth
0.00%
-314789
-0.42%
-0.43%
SBI MNC Direct Plan-Growth
0.00%
-280000
-2.20%
-2.19%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.00%
-260056
-2.46%
-2.53%
Edelweiss Mid Cap Direct Plan-Growth
0.00%
-244609
-0.96%
-1.01%
Edelweiss Small Cap Fund Direct - Growth
0.00%
-210627
-1.92%
-2.01%
ICICI Prudential Commodities Fund Direct - Growth
0.00%
-201440
-3.04%
-3.23%
Aditya Birla Sun Life Mid Cap Direct Fund-Growth
0.00%
-195519
-1.50%
-1.38%
ICICI Prudential Midcap Direct Plan-Growth
0.00%
-190789
-1.34%
-1.38%
Axis Flexi Cap Fund Direct-Growth
0.00%
-188228
-0.67%
-0.69%
Aditya Birla Sun Life Large & Mid Cap Fund Direct -Growth
0.00%
-183508
-1.49%
-1.52%
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth
0.00%
-150832
-1.29%
-1.33%
Canara Robeco Equity Hybrid Fund Direct-Growth
0.00%
-146500
-0.61%
-0.67%
ICICI Prudential Manufacturing Fund Direct - Growth
0.00%
-140803
-0.98%
-1.13%
HDFC Large and Mid Cap Fund Direct- Growth
0.00%
-136771
-0.23%
-0.25%
Tata Mid Cap Direct Plan-Growth
0.00%
-130000
-1.19%
-1.23%
SBI Equity Savings Fund Direct-Growth
0.00%
-128205
-0.96%
-1.05%
HDFC Innovation Fund Direct-Growth
0.00%
-125378
-2.23%
-2.33%
Edelweiss Multi Cap Fund Direct - Growth
0.00%
-110229
-1.73%
-1.79%
Baroda BNP Paribas Multi Cap Fund Direct-Growth
0.00%
-105400
-1.65%
-1.69%
Mirae Asset Small Cap Fund Direct-Growth
0.00%
-104279
-2.00%
-1.19%
Baroda BNP Paribas Midcap Fund Direct-Growth
0.00%
-100000
-2.11%
-2.17%

Technical Indicators

RSI(14)
Overbought
83.10
ATR(14)
Less Volatile
203.42
STOCH(9,6)
Neutral
67.74
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
119.34
ADX(14)
Strong Trend
32.79
UO(9)
Bearish
65.86
ROC(12)
Uptrend And Accelerating
19.03
WillR(14)
Overbought
-4.57

About Navin Fluorine International

Navin Fluorine International Limited is an Indian company specializing in fluorine chemistry. It manufactures refrigeration gases, inorganic fluorides, and specialty organofluorines. The company operates manufacturing units in Surat, Gujarat and Dewas, Madhya Pradesh, with an additional site in Dahej, Gujarat. Navin Fluorine provides contract research and manufacturing services, focusing on the production of fluorine-based chemicals for various industries including pharmaceuticals, agrochemicals, and petrochemicals. The company has developed over 40 commercial products and serves several Fortune 500 companies. In recent years, Navin Fluorine has expanded its operations, including the establishment of a High Performance Products business at Dahej and investments in new manufacturing capabilities.
Chairperson NameV P Mafatlal